These findings are consistent with a recent report that NME2 binds the telomere repeat binding factor 2 in the nucleus to reduce telomerase activity [37], suggesting a mechanistic link between NME2 expression and survival of cancer cells. This evidence concerns the gene TERF2 and cancer.